Financial results - SPRINTEAN PHARM SRL

Financial Summary - Sprintean Pharm Srl
Unique identification code: 29228245
Registration number: J30/791/2011
Nace: 4773
Sales - Ron
46.653
Net Profit - Ron
-11.793
Employee
1
The most important financial indicators for the company Sprintean Pharm Srl - Unique Identification Number 29228245: sales in 2022 was 46.653 euro, registering a net profit of -11.793 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Sprintean Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 39.896 34.428 31.396 35.018 41.691 49.678 41.059 52.652 46.795 -
Total Income - EUR 41.505 35.341 32.136 36.020 42.612 49.692 41.075 52.684 46.844 -
Total Expenses - EUR 41.310 33.268 30.419 34.657 44.747 54.486 44.485 48.942 58.210 -
Gross Profit/Loss - EUR 195 2.073 1.717 1.363 -2.135 -4.794 -3.410 3.742 -11.366 -
Net Profit/Loss - EUR -1.050 1.013 1.074 1.003 -2.561 -5.307 -3.783 3.210 -11.829 -
Employees 1 1 1 1 1 2 2 1 1 -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -11.4%, from 52.652 euro in the year 2021, to 46.795 euro in 2022. The Net Profit decreased by -3.220 euro, from 3.210 euro in 2021, to 0 in the last year.

Check the financial reports for the company - Sprintean Pharm Srl

Rating financiar

Financial Rating -
Sprintean Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Sprintean Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sprintean Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Sprintean Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sprintean Pharm Srl - CUI 29228245

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 15.560 15.690 15.530 15.267 20.441 20.045 19.665 19.229 19.288 -
Current Assets 13.492 11.672 10.736 13.371 10.145 11.236 16.898 15.446 47.269 -
Inventories 4.594 3.914 4.377 4.415 2.559 2.463 2.819 1.253 7.259 -
Receivables 4.185 1.873 430 2.335 4.513 3.882 4.321 13.023 33.262 -
Cash 4.713 5.885 5.928 6.621 3.073 4.890 9.758 1.170 6.748 -
Shareholders Funds -2.377 -1.384 -296 712 -1.862 -7.133 -10.781 -7.331 -19.183 -
Social Capital 0 0 0 0 0 0 0 0 0 -
Debts 31.429 28.746 26.561 27.926 32.448 38.414 47.344 42.006 85.741 -
Income in Advance 0 0 0 0 0 0 0 0 0 -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 47.269 euro in 2022 which includes Inventories of 7.259 euro, Receivables of 33.262 euro and cash availability of 6.748 euro.
The company's Equity was valued at -19.183 euro, while total Liabilities amounted to 85.741 euro. Equity decreased by -11.829 euro, from -7.331 euro in 2021, to -19.183 in 2022.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Sprintean Pharm Srl

Comments - Sprintean Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.